119th Congress · introduced in the Senate · Sep 18, 2025
Safe Step Act
Official title from Congress.gov
Latest action (Mar 19, 2026): Committee on Health, Education, Labor, and Pensions. Hearings held.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Committee on Health, Education, Labor, and Pensions. Hearings held.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Actions from Congress.gov, newest first.
Congressional oversight · Drug therapy · Government information and archives · Health care costs and insurance · Prescription drugs
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
119 citations; showing the 25 most recently posted.
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: THE KPM GROUP DC LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$10,000
Paid to lobbying firm
HR 5509/S.2903 Safe Step Act HR 6423/S. 864 HELP Copays Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EPILEPSY FOUNDATION · lobbying firm or registrant: EPILEPSY FOUNDATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$90,000
Spent on own lobbying
…ith the Independent Dispute Resolution (IDR) process -S. 5428/H.R. 930, Stop the Wait Act, support passage -Requests to join the Congressional Epilepsy Caucus -S. 2903/H.R. 5509, Safe Step Act, support passage -S. 864/H.R. 6423, HELP Copays Act, support passage -WISeR Model, express concern with how it could impede access to…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
…9: Priority for Pediatric Cures Act ---S.822: Scientific EXPERT Act ---Rare Disease Pilot Program Reimbursement and Coverage of Innovative Products ---H.R.5509/S.2903:SAFE STEP Act ---S.864/H.R.6423: HELP Copays Act ---Access to Innovative Treatments ---CMMI Authority ---Implementation of the Inflation Reduction Act (IRA) of…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Insurance
$3,010,000
Spent on own lobbying
…e transparency requirements S. 2420 - No Surprises Act Enforcement Act - Sen. Marshall, Roger - Surprise billing penalties for noncompliance by health insurers S. 2903 - Safe Step Act - Sen. Murkowski, Lisa - Step therapy requirement S. 3599 - Affordable CHOICE Act - Sen. Whitehouse, Sheldon - public option under ACA S. 4189…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BAYER CORPORATION (CONSOLIDATED REPORT) · lobbying firm or registrant: BAYER CORPORATION (CONSOLIDATED REPORT)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$1,710,000
Spent on own lobbying
…6, Dietary Supplement Regulatory Uniformity Act. H.R. 8933, Dietary Supplements Access Act. H.R. 9090, Advancing Menopause Care and Mid-Life Womens Health Act. S. 2903, Safe Step Act. S. 3122, Better Food Disclosure Act of 2025. S. 3677, Dietary Supplement Listing Act of 2026. S. 3788, CLEAR Labels Act. S. 4503, Advancing Men…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ABBVIE INC. · lobbying firm or registrant: ABBVIE, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$1,050,000
Spent on own lobbying
S. 864, HELP Copays Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act S. 2903, Safe Step Act H.R. 5509, Safe Step Act H.R. 8630, The Protecting Equal Access to Thyroid Act of 2026 Drug cost and pricing policy issues Patient affordability…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
JOHNSON & JOHNSON SERVICES INC · lobbying firm or registrant: JOHNSON & JOHNSON SERVICES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$2,220,000
Spent on own lobbying
…Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Ac…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ACADEMY OF NEUROLOGY · lobbying firm or registrant: FAEGRE DRINKER BIDDLE & REATH LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$50,000
Paid to lobbying firm
Support BRAIN Initiative and VA Neurology Centers of Excellence appropriations; Support H.R. 9693 Patients First Act; Support H.R. 5509/S. 2903 SAFE STEP Act; Support H.R. 3514/S.1816 Seniors Timely Access to Care Act; Support H.R. 929/S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorizat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CROHN'S & COLITIS FOUNDATION · lobbying firm or registrant: FAEGRE DRINKER BIDDLE & REATH LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$30,000
Paid to lobbying firm
Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509/S.2903); Congressional Crohn's & Colitis Caucus; Issues pertaining to the FDA review of therapies to treat pediatric IBD.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALKERMES, INC. · lobbying firm or registrant: ALKERMES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$970,000
Spent on own lobbying
Ensure patient access to appropriate medications by limiting the unnecessary use of utilization management policies, including H.R. 5509/S. 2903 the Safe Step Act; Awareness of need for transparency and patient access within the 340B program; Awareness of sleep disorders, such as Narcolepsy Type 1, Type…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN PSYCHIATRIC ASSOCIATION · lobbying firm or registrant: AMERICAN PSYCHIATRIC ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$144,050
Spent on own lobbying
…Teaching Health Center Graduate Medical Education (THCGME) H.R.3505/S.5558 - Barriers to Suicide Act H.R. 5434/S. 2826 - 988 LGBTQ+ Youth Access Act H.R.5509 /S.2903 - Safe Step Act H.R. 5557 - Mental Health Services for Students Act H.R. 3514/S.1816 - Improving Seniors Timely Access to Care Act S. 3064 - Relief of Chronic…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF GASTROENTEROLOGY · lobbying firm or registrant: ALSTON & BIRD LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In g…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
TOURETTE ASSOCIATION OF AMERICA · lobbying firm or registrant: TOURETTE ASSOCIATION OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$60,000
Spent on own lobbying
…Broadly Telehealth (including HR 4206/ S 1261 - Connect for Health Act of 2025) H.R. 3514/S.1816- Improving Seniors Timely Access to Care Act of 2025 H.R. 5509/S. 2903- Safe Step Act of 2025 H.R. 10210- Doctors Not AI Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$1,790,000
Spent on own lobbying
…interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act,…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · lobbying firm or registrant: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$2,047,000
Spent on own lobbying
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025 Clinical Laboratory Improvement Amendment
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL HEALTH COUNCIL · lobbying firm or registrant: NATIONAL HEALTH COUNCIL
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$21,227
Spent on own lobbying
…mely Access to Care Act. S. 1717/H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act. H.R. 3521/S. 4440, Clinical Trial Modernization Act. S. 2903/H.R. 5509, Safe Step Act. FY 2027 Labor, HHS, Education appropriations for programs affecting people with chronic diseases and disabilities. S. 494/ H.R.1189 N…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASTRAZENECA PHARMACEUTICALS LP · lobbying firm or registrant: TODD STRATEGY GROUP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Pharmacy
$80,000
Paid to lobbying firm
…r pharmaceuticals. Pharmaceutical supply chain manufacturing. Pharmaceutical pricing negotiations. H.R.3521/S.4440: Clinical Trials Modernization Act. H.R.5509/S.2903: Safe Step Act. H.R.946/S.1862: Optimizing Research Progress Hope and New Cures (ORPHAN Cures) Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ACADEMY OF NEUROLOGY · lobbying firm or registrant: AMERICAN ACADEMY OF NEUROLOGY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Insurance
$270,000
Spent on own lobbying
-Safe Step Act, H.R. 5509 / S. 2903 -Issues related to step therapy reform -Issues related to telehealth access -Issues related to utilization management reform
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) · lobbying firm or registrant: RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Health Issues
$60,000
Spent on own lobbying
…aves Lives Reauthorization Act of 2025; FY 2027 Appropriations; FDA user fee reauthorization; H.R. 7118 - Genomic Answers for Children's Health Act; H.R. 5509, S. 2903 - Safe Step Act; H.R. 1414 - Cameron's Law; H.R. 10359 - Priority for Pediatric Cures Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY · lobbying firm or registrant: AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Health Issues
$388,538
Spent on own lobbying
…0/S.2420, No Surprises Act Enforcement Act. H.R.4731/S.2439, Resident Physician Shortage Reduction Act of 2025. H.R.5435/S.2842, Stop CMV Act of 2025. H.R.5509/S.2903, Safe Step Act. H.R. 5736, Penicillin Allergy Verification and Evaluation (PAVE) Act. H.R.6160, Strengthening Medicare for Patients and Providers Act. H.R. 752…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY · lobbying firm or registrant: AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Insurance
$388,538
Spent on own lobbying
…H.R.3514/S.1816, Improving Seniors' Timely Access to Care Act of 2025. H.R.4606/S.3400, Ally's Act. H.R.4710/S.2420, No Surprises Act Enforcement Act. H.R.5509/S.2903, Safe Step Act. S.1105, No UPCODE Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY · lobbying firm or registrant: AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Pharmacy
$388,538
Spent on own lobbying
H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services (ECAPS) Act. H.R.5509/S.2903, Safe Step Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Medicare/Medicaid
$40,000
Spent on own lobbying
…rs Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act H.R. 9693/S. 5672 - Patients First Act of 2026 H.R. 4583/S. 1552 - Living Donor Pro…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Health Issues
$40,000
Spent on own lobbying
…rs Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act H.R. 9693/S. 5672 - Patients First Act of 2026 H.R. 4583/S. 1552 - Living Donor Pro…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF SURGEONS · lobbying firm or registrant: AMERICAN COLLEGE OF SURGEONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Medicare/Medicaid
$230,000
Spent on own lobbying
…rs Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act H.R. 9693/S. 5672 - Patients First Act of 2026 H.R. 4583/S. 1552 - Living Donor Pro…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing